The U.S. Food and Drug Administration has chastised Allergan for what it called "misleading" advertising for popular anti-wrinkle drug Botox. Among other things, the agency said the ads fail to ...

The medical aesthetics market, valued at $15.4 billion in 2023, is expected to grow to $25.9 billion by 2028. In their searches for more market share, well-known aesthetics brands like Botox are ...

CHICAGO, Feb 1 (Reuters) - The maker of the wrinkle-smoothing blockbuster drug Botox -- used by Hollywood's elite and news anchors everywhere -- is taking jokes about its most famous product seriously ...

Three Instagram ads for cosmetic procedures featuring photos of Kim Kardashian and Kylie Jenner have been banned for “misleading” consumers. Two of the ads – one for beauty salon Queen of Aesthetics ...

In this video, we delve into the lucrative world of Botox and explore how it intersects with digital marketing strategies ...

LOS ANGELES (Reuters) - Print and television ads for the wrinkle-smoothing drug Botox are misleading and should be pulled until they are changed, the US Food and Drug Administration told the drug's ...

IRVINE, Calif. -- The maker of Botox, the wrinkle-smoothing botulism toxin, is refusing a demand by the Food and Drug Administration to pull ads the agency says are misleading. Allergan Inc. reacted ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

For Allergan Inc., a subtle offense has proved the best defense in the court of public opinion over Botox. Observers give the Irvine drug maker good marks for its strategy in support of Allergan’s ...